Ovarian cancer super root treatment, the hope of giving birth to advanced patients

The incidence of ovarian cancer is ranked third in gynecological malignant tumors, but because of the concealment of the onset, early symptoms are not obvious. 70%of the patients with ovarian cancer have clearly diagnosed as advanced. It is "the king of women".

At present, ovarian cancer's main treatment methods are mainly surgical, supplemented by chemotherapy and subsequent targeting maintenance treatment. This is because the degree of tumor reduction (the degree of surgical removal of tumor) is directly related to the prognosis of ovarian cancer patients. In addition, chemotherapy is highly effective for ovarian cancer, which can reduce the recurrence rate and improve the efficacy.

However, because patients with patients with advanced ovarian cancer basically occur when the abdominal cavity and pelvic cavity are basically metastasized during the consultation, conventional surgery can be satisfied with the proportion of satisfaction reduction, and the surgery is difficult and risky. It is difficult to implement. To this end, the Gynecological Oncology Center of Chongqing University Affiliated Oncology Hospital took the lead in carrying out ovarian cancer super root treatment (hereinafter referred to as "super root treatment") in the region, and the thorough reduction (R0) rate was significantly improved.

Ms. Wang, 52, was diagnosed with high -grade ovarian larvae cancer due to bloating and abdominal pain half a year ago. She was diagnosed with high -level ovarian larvae cancer. It was accompanied by multiple metastasis such as the liver and spleen, pleural, pelvic cavity, and was already in advanced stage. Ms. Wang said that she was told that she could not surgery while she was clinic in many hospitals.

Recommended by the sick friend, Ms. Wang came to the Cancer Hospital of Chongqing University to discuss and discuss it with a multi -disciplinary diagnosis and treatment at the gynecological tumor center.

In the past 12 hours of surgery, the gynecological tumor center combined MDT, and the tumors of Ms. Wang's body in multiple organs were cleaned through carpet search to achieve the best satisfaction reduction state (called R0). At present, patients have recovered well after surgery and accepted postoperative chemotherapy.

According to reports, ovarian cancer super root treatment includes diaphragmistorization, spleen resection, pancreatic partial sketching, gallbladder divorce, bowel dehumidification, gastric division and liver resection. Surgery, etc., is difficult and complicated in operation. Experts need to be familiar with multiple parts of anatomy and skilled surgery. If necessary, MDT is on the stage.

Related clinical studies have proved that surgical removal of all the optical prognostic prognostic factor for the most important independent prognosis of advanced ovarian cancer, and the first treatment of R0 surgical resection has benefited more than the survival of R0 surgical resection after neoading chemotherapy.

"Super root treatment is suitable for most patients with ovarian cancer. For such patients, it is difficult to achieve the effect of satisfying tumors. Director Zou Dongling said that in order to improve the 5 -year survival rate of patients, the gynecological tumor center has always adhered to the norms and forefronts. Under the leadership of the older generation, ovarian cancer super root treatment has been carried out since 2011, and 2,000 cases have been completed so far.

Gynecology and Cancer Center of Cancer Hospital Affiliated to Chongqing University

Chongqing University Affiliated Oncology Hospital has a key discipline of national oncology. The gynecological and tumor center is Chongqing's key discipline, Chongqing Municipal Obstetrics and Gynecology Department, Chongqing Cervical Cancer Early Treatment Center, PhD in Chongqing University, Master's Degree Training point. The discipline has a medical team with exquisite medical skills and priority to patients. There are members of the International Women's Cancer Alliance (IGCS) Education Commission, chairman of the China Anti -Cancer Association Cancer Endocrine Special Committee, former chairman of the Chinese Anti -Cancer Association Gynecology and Cancer Special Committee, Executive Director of the China Anti -Cancer Association and the National First and secondary Society Wait for many people. There are government allowance experts, second -level professors, Chongqing Municipal Medical Experts, Chongqing Municipal Medical Masters, and Chief Expert Studio of Chongqing Cancerology. There are 320 beds in this center, with an annual outpatient number of more than 50,000 people, more than 15,000 people in the hospital, nearly 90%of malignant tumors, and nearly 3,000 annual surgery, including more than 75%of the III and IV surgery.

This center is committed to clinical, scientific research and teaching of gynecological malignant tumors, takes the lead in formulating clinical paths and diagnosis and treatment specifications for gynecological tumors, make full use of surgical, radiotherapy, chemotherapy, immunotropic treatment, innovative clinical research, adhere to the standardization of tumor treatment, realize gynecological gynecology department The precision and individualization of malignant tumors has always been based on improving the prognosis of patients. The five -year survival rate of gynecological tumors ranks leading in China. Base and demonstration base.

The Center has launched a gynecological malignant tumor multi -disciplinary expert for more than 10 years. Adhere to the best individualized treatment plan for patients with gynecological tumors, routinely carry out minimally invasive surgery such as cervical cancer screening and precancerous lesion diagnosis and treatment, laparoscopic robotics, cervical cancer root treatment, ovarian cancer reduction, ovarian cancer super root treatment surgery , Endometrial cancer phase, vulvar cancer root treatment, and the first domestic cervical cancer treatment, recurrence cervical cancer centers lesion resection, pelvic outline, recurrence ovarian cancer secondary tumor, vulva, vulva, and vulva Cancer root treatment and plastic surgery, precise and strong radiotherapy of gynecological malignant tumors and three -dimensional lattice (painless) post -loading, recurrent tumor rescue treatment, immunotherapy, gynecological malignant tumor gene test and genetic consultation.

This center rely on the medical facilities of the hospital-equipped with the skilled rail CT and radiotherapy during surgery, organs-like transformation research laboratories, large medical equipment: Da Vinci XI, PET-CT, MRI, 128 row spiral CT, CT, 128 row spiral CT, Rotating tuning straight line accelerator, spiral fault radiation therapy system, with the latest three-dimensional rear installation, fluorescence/3D/high-definition laparoscopy, hysteroscopy, Aerbo surgery workstation, heat irrigation treatment instrument, ultrasonic knife, blood vessel closed system, optics-optics- A variety of gynecological tumors such as electronic vaginal mirrors, Ruifu knives, and Haifu treatment instruments are diagnosed and comprehensive treatment of gynecological tumors. This center has carried out tumor clinical drug test for more than 20 years, which is a demonstration center of gynecological malignant tumor clinical research. Since 2013, he has participated in more than 10 international multi -center clinical research as one of the domestic centers. At present, 123 clinical research projects initiated by the international and domestic multi -center clinical research and researchers have provided patients with more individualized treatment options for patients to optimize the treatment path, improve the prognosis, and improve the quality of life.

The center hosted the scientific research projects with major special projects, two National Natural Science Foundation projects, more than 10 national and provincial and ministerial scientific research projects, more than 30 editor -in -chief and editor -in -chief of the past 5 years, published more than 150 SCI and high -quality papers, The highest influence factor was 35.3 points, won 1 second prize of the Chongqing Municipal Government Scientific and Technological Progress, 1 provincial and ministerial scientific and technological progress award, and the first prize of the bureau -level scientific and technological achievement award.

The center has a complete gynecological tumor medical teaching management system, trains scientific research, doctoral doctoral and master's degree, and receives training of gynecological tumor specialists all year round.

The Gynecology and Cancer Center of Chongqing University Affiliated Cancer Hospital strives to be an industry model and provides high -quality medical and services to female friends!

- END -